Clinical Trial Update: Beta Alethine in Treating Patients With Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Beta Alethine for treating multiple myeloma and related plasma cell neoplasms, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Beta Alethine (beta alethine)

Snippet

Sponsor: LifeTime Pharmaceuticals | Conditions: Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 1, Phase 2 | Status: UNKNOWN